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In December 2013, we reported a Clostridium difﬁcile (CD)
outbreak caused by the hyper-virulent ribotype 027 in the
Provence-Alpes-Côte d’Azur (PACA) area, southeastern
France [1]. Sixty-one patients were hospitalized from March
2013 to April 2014 in the four university hospitals of Marseille
(Timone, Conception, North and Sainte-Marguerite) for CD
027 infection, with a mortality of 43% [2]. Following this
outbreak, we developed an automated epidemiological sur-
veillance system for CD cases.
Cloatridium difﬁcile is associated with an elevated lethality
worldwide [2–4]. This lethality has gradually increased,
exceeding that of many other bacterial species. In the present
retrospective study, from January 2012 to December 2015, we
compared the lethality rates of CD isolated in enterocolitis and
the three most common bacterial pathogens isolated from any
specimen (Escherichia coli, Staphylococcus aureus and Pseudo-
monas aeruginosa) in the university hospitals of Marseille, in the
PACA area, France. The analysed data include the numbers ofw Microbe and New Infect 2016; 14: 6–7
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species and the associated lethality for patients over 65 years
old. The data at the Marseille and regional levels were obtained
using our epidemiological surveillance system whereas national
data were obtained by the medical information service in
Timone hospital (National Data obtained by Convention de droit
d’usage des données PMSI, N°d’agrément 2015-111111-88-46).
Duplicates were removed. For a given patient, only the ﬁrst
infection caused by a given microorganism was registered. We
calculated the annual lethality rates (for the years 2012 to 2015)
by dividing the number of deaths by the number of patients
affected by the respective bacterial species by each year. All
data collection and descriptive epidemiological analyses were
performed in EXCEL.
Within Marseille university hospitals, we observed a stable
lethality rate of E. coli urinary-tract infections between 2012 and
2015 (3.6%–5.6%, Table 1). For E. coli bacteraemia, the lethality
increased from 2012 to 2014 (11.8%–18.3%, Table 1) and
decreased in 2015 (10.7%). For S. aureus bacteraemia, the
lethality decreased constantly from 22.9% in 2012 to 19.1% in
2014 (Table 1) then increased in 2015 (20.3%). For P. aeruginosa
bacteraemia the lethality increased from 2012 (28.6%) to 2013
(31.7%), then decreased in 2014 (23.1%) and increased in 2015
(30.4%; Table 1). TheCD lethality ratewas lower in 2012 (10.6%)
than in other years and reached a peak of 18.3% in 2013 (1.7-fold
increase) and then decreased in 2014 (17.9%) and 2015 (12.4%).
At the PACA level, in 2012, 2013 and 2014, the lethality rate
of CD infections was also lower than those of other pathogens
(Table 1). At the country level, the highest lethality rate in 2012
and 2013 was that of P. aeruginosa, which was slightly higher
than that of C. difﬁcile.
When considering the evolution of lethality rates over time
(Table 1), we observed that CD-related mortality had the
greatest variation among bacterial pathogens in Marseille and
PACA, which may be explained by the 2013–2014 CD 027
outbreak [2]. We also observed a great reduction in CD-
related lethality in 2015, although non-signiﬁcant (two-sided
Pearson’s chi-square test, p 0.09). This reduction followed the
implementation of systematic faecal microbiota transplantation
for patients hospitalized in Marseille university hospitals with
CD 027 infections [2].
Together, these results conﬁrmed that CD is a major life-
threatening bacterial pathogen, especially for the elderly, like
P. aeruginosa. This conﬁrms what was previously observed in
our region [1,5] and also in northern France and other coun-
tries [6,7]. The rapid decrease in the lethality of CD infections
in Marseille university hospitals (18.3% to 12.4%) and the PACAobiology and Infectious Diseases
nses/by-nc-nd/4.0/)
TABLE 1. Number of deaths and lethality rate of infection caused by Clostridium difﬁcile and the three most common bacterial
pathogens in Marseille university Hospitals, Provence-Alpes-Côte d’Azur region and France from January 2012 to December 2015
Bacterial species




















Global mortalityb 30 890 1581 5.1 339 182 19 037 5.6 3 502 943 215 945 6.2
Clostridium difﬁcile 47 5 10.6 566 86 15.2 7500 1288 17.2
Escherichia coli bacteraemia 136 16 11.8 1146 298 26.0 10 752 2575 23.9
Escherichia coli UTI 380 21 5.5 8 562 688 8.0 97 357 5891 6.1
Staphylococcus aureus bacteraemia 105 24 22.9 660 238 36.1 8131 2539 31.2
Pseudomonas aeruginosa bacteraemia 28 8 28.6 324 131 40.4 3028 1176 38.8
2013
Global mortalityb 31 723 1583 5.0 347 520 19 220 5.5 3 588 311 215 303 6.0
Clostridium difﬁcile 142* 26* 18.3 710 142 20.0 8461 1511 17.9
Escherichia coli bacteraemia 133 22 16.5 1201 313 26.1 11 574 2923 25.3
Escherichia coli UTI 478 17 3.6 9023 642 7.1 103 746 6549 6.3
Staphylococcus aureus bacteraemia 104 21 20.2 687 222 32.3 7988 2669 33.4
Pseudomonas aeruginosa bacteraemia 41 13 31.7 333 122 36.6 3155 1168 37.0
2014
Global mortalityb 32 335 1559 4.8 356 108 19 427 5.5 3 695 116 216 734 5.9
Clostridium difﬁcile 148 27 18.2 914 175 19.1 8883 1580 17.8
Escherichia coli bacteraemia 197 36 18.3 1365 310 22.7 13 069 3095 23.7
Escherichia coli UTI 534 29 5.4 9679 733 7.6 110 565 6939 6.3
Staphylococcus aureus bacteraemia 173 33 19.1 771 269 34.9 8350 2774 33.2
Pseudomonas aeruginosa bacteraemia 52 12 23.1 404 126 31.2 3325 1158 34.8
2015
Global mortalityb 32 555 1645 5.1 N/A N/A N/A 3 836 118 229 608 6.0
Clostridium difﬁcile 153* 19* 12.4 N/A N/A N/A 11 336 1972 17.4
Escherichia coli bacteraemia 242 26 10.7 N/A N/A N/A 21 901 4152 19.0
Escherichia coli UTI 1 111 62 5.6 N/A N/A N/A 114 962 7507 6.5
Staphylococcus aureus bacteraemia 143 29 20.3 N/A N/A N/A 11 481 3608 31.4
Pseudomonas aeruginosa bacteraemia 56 17 30.4 N/A N/A N/A 4301 1483 34.5
UTI, urinary tract infection.
*p 0.09, not signiﬁcant.
aNational Data obtained by: Convention de droit d’usage des données PMSI, N°d’agrément 2015-111111-88-46.
bIncludes all causes of death, infectious or not.
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for all patients in PACA, the faecal microbiota transplantation
[5].
Our study demonstrated that the CD-related lethality was
similar in Marseille university hospitals and at the regional and
national levels and was lower than those caused by P. aeruginosa
or S. aureus. CD remains a major public health concern.
Moreover, our results should encourage hospitals to exten-
sively survey CD infections by the implementation of automatic
monitoring systems, and also by developing rapid screening
procedures to identify and isolate infected patients and healthy
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